Neurology Grand Rounds

Location

• Clinical Academic Building
  125 Paterson Street
  Conference Room 1302
  New Brunswick
  
• Medical Education Building
  Conference Room 102
  New Brunswick
  

Time: 1:30 PM – 2:30 PM

Grand Rounds Archive

Click Here to view previous Grand Rounds

The UMDNJ-Center for Continuing and Outreach Education is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical Education for physicians.

The UMDNJ-CCO designates this educational activity for a maximum of 1 credit AMA PRA Category 1 credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For additional information contact:
Laurie Lipper, Grand Rounds Coordinator
RWJMS – Dept. of Neurology
97 Paterson Street
New Brunswick , New Jersey 08901
Phone: (732) 235-7337 or Email: lipperla@umdnj.edu

09/16/09: Dystonia - Genotypes and Phenotypes
Location: CAB 1302

Susan Bressman, MD
Chair, Mirken Department of Neurology
Beth Israel Medical Center
Professor of Neurology
Albert Einstein College of Medicine

Learning Objective: To become familiar with genetic approaches and findings in dystonia and how these findings impact clinical practice.

09/23/09: Case Presentation
Location: CAB 1302

09/30/09: Advances in the Symptomatic Management of Multiple Sclerosis
Location: CAB 1302  

Christopher T. Bever, Jr., MD, MBA
Professor of Neurology
Pharmacology and Physical Therapy
University of Maryland, School of Medicine
Director,  VA MS Center of Excellence East

Learning Objective: To recognize the role of potassium channels in the pathophysiology of demyelination, the mechanism of potassium channel blockade and the evidence that potassium channel blockers can improve symptoms in patients with multiple sclerosis.

10/07/09: Case Presentation
Location: CAB 1302

10/14/09: Urological Evaluation & Management of Voiding Disorders in Parkinson's Disease

Location: MEB 102

Hari Tunuguntla, MD, MCh
Assistant Professor, Division of Urology
Director, Neuro-Urology, Voiding Dysfunction, Urodynamics & Female Urology
UMDNJ/RWJMS

Learning Objective: To recognize the urological perspectives on prevalence, impact, presentation, evaluation and management of bladder problems and voiding dysfunction in patients with Parkinson's Disease.

10/21/09: Acute Ischemic Stroke Treatment: The Evidence and Beyond

Location: CAB 1302    

Scott E. Kasner, MD, MSCE, FAHA
Professor of Neurology
Director, Comprehensive Stroke Center
University of Pennsylvania Medical Center

Learning Objective: To recognize the available treatment options for patients with acute ischemic stroke.

10/28/09: Case Presentation
Location: CAB 130

11/04/09 Case Presentation
Location: CAB 1302

11/11/09: Newer Concepts in Multiple Sclerosis
Location: MEB 102    

Stuart D. Cook, MD
Ruth Dunietz Kushner and Michael Jay Serwitz
Professor of Neurology and Neurosciences
UMDNJ-NJMS

Learning Objective: To become familiar with the current concepts of MS etiology and therapy.

11/18/09: Current Concepts in Hereditary and Acquired Peripheral Neuropathey
Location: MEB 102

Jonathan P. Goldstein, MD
Clinical Vice Chairman
Department of Neurology
Yale University School of Medicine

Learning Objective: To become familiar with: (1) the diagnosis of hereditary and acquired neuropathy; (2) the management of hereditary and acquired neuropathy; (3) future directions in hereditary and acquired neuropathy.

12/02/09: Blood Pressure Management in Acute Stroke – An Evidence Based Approach
Locations: MEB 102  

James McKinney, III, MD
Assistant Professor
Department of Neurology
UMDNJ-RWJMS

Learning Objective:  To understand a treatment algorithm for blood pressure management in acute stroke.

12/09/09: More Mischief Associated with Natalizumab Treatment of Multiple Sclerosis
Location: MEB 102   

Michael K. Racke, MD
Professor and Chairman of Neurology
The Helen C. Kurtz Chair in Neurology
The Ohio State University Medical Center

Learning Objective: To recognize the  role of various cytokines and transcription factors that are involved in making T cells pathogenic in experimental models of multiple sclerosis.

12/16/09 Case Presentation
Location: MEB 102